Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

Journal of cardiovascular pharmacology and therapeutics - 1 Mar 2009

Kostapanos Michael S, Milionis Haralampos J, Filippatos Theodosios D, Christogiannis Leonidas G, Bairaktari Eleni T, Tselepis Alexandros D, Elisaf Moses S

Abstract excerpt

Although the raising effect of rosuvastatin on high-density lipoprotein cholesterol is well-established, there is a paucity of data regarding the effect of this statin on the high-density lipoprotein subfraction phenotype. A total of 150 participants without evidence of cardiovascular disease were randomized to therapeutic lifestyle modification (nonstatin-treated group) or to therapeutic lifestyle modification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 1-Alkyl-2-acetylglycerophosphocholine Esterase
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aryldialkylphosphatase

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipidemias

Share to Risk Reduction Behavior

Share to Rosuvastatin Calcium

Share to Sulfonamides

Source

Identifiers

PMID: 19246334
DOI: 10.1177/1074248408331031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.PMID 19246334Read ↗

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.Semantic proximity Read ↗

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.Semantic proximity Read ↗

High-density lipoprotein subfractions--what the clinicians need to know.Semantic proximity Read ↗

Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).Semantic proximity Read ↗

Atheroprotective Effects of High-Density LipoproteinsSemantic proximity Read ↗

Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.Semantic proximity Read ↗

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.Semantic proximity Read ↗

Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training.Semantic proximity Read ↗

[Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.